Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A function-structure model for NGF-activated TRK

M E Cunningham1, L A Greene

  • 1Department of Pathology and Center for Neurobiology and Behavior, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

The EMBO Journal
|December 19, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between physical activity, structural deformity, and spinal mobility in adolescent idiopathic scoliosis patients.

Spine deformity·2023
Same author

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.

Cell death & disease·2014
Same author

Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children.

Journal of thrombosis and haemostasis : JTH·2014
Same author

A feed-forward loop involving Trib3, Akt and FoxO mediates death of NGF-deprived neurons.

Cell death and differentiation·2013
Same author

Use of global assays to understand clinical phenotype in congenital factor VII deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.

Oncogene·2011
Same journal

Scalable phosphotyrosine enrichment with SH2 superbinder enables deep profiling of EGF responses.

The EMBO journal·2026
Same journal

Essential nucleus-apical pole linkage maintains division fidelity during Plasmodium progeny formation.

The EMBO journal·2026
Same journal

From cell atlases to mechanisms: bridging scRNA-seq discovery with in vivo genetics.

The EMBO journal·2026
Same journal

Mitochondrial calcium regulates lipid metabolism by modulating tethering of mitochondria to lipid droplets.

The EMBO journal·2026
Same journal

Chromosome condensation mechanically primes the nucleus for mitosis.

The EMBO journal·2026
Same journal

NDR kinase SAX-1 controls dendrite branch-specific elimination during neuronal remodeling in C. elegans.

The EMBO journal·2026
See all related articles

This study reveals how receptor tyrosine kinases (RTKs) activate. Specific charge pairs stabilize the active state, enabling cell signaling and providing new targets for drug development.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Receptor tyrosine kinases (RTKs) are crucial cell signaling proteins.
  • Understanding RTK activation mechanisms is vital for disease research.

Purpose of the Study:

  • To investigate the 'switch' model of RTK activation.
  • To identify specific residues involved in TRK receptor activation.

Main Methods:

  • Utilized functional biological assays.
  • Employed mutated TRK receptors to test the activation model.

Main Results:

  • Provided evidence supporting the 'switch' model for RTK activation.
  • Identified specific charge pairs between phosphotyrosines and basic residues in TRK activation loops.

Related Experiment Videos

  • Demonstrated how these charge pairs stabilize the active kinase conformation.

    • Conclusions:

    • The 'switch' model accurately describes RTK activation.
    • Specific residue interactions are key to stabilizing active RTKs.
    • Findings offer potential therapeutic targets for modulating RTK activity.